Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinfukang Oral Liquid Combined With Chemotherapy in Advanced NSCLC
NCT05098990Phase 4Unknown
- Sponsor
- China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
- Start
- Oct 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of jinfukang in non-small cell lung cancer (NSCLC), sponsored by China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
jinfukang
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05098990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05098990.